Ana Cândida Araújo Silva

Dr. Ana Cândida Araújo Silva

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
CSCristina Maria de Souza
Cristina Maria de Souza
ASAna Cândida Araújo Silva
Ana Cândida Araújo Silva
CFClarissa de Jesus Ferraciolli
Clarissa de Jesus Ferraciolli
GMGiovanna Vieira Moreira
Giovanna Vieira Moreira
LCLiliane Cunha Campos
Liliane Cunha Campos
Geovanni Dantas CassaliGeovanni Dantas Cassali
Geovanni Dantas Cassali

Verified
Journal Article
Open access
PDF file
KFKatia Michelle Freitas
Katia Michelle Freitas
ASAna Cândida Araújo Silva
Ana Cândida Araújo Silva
EVEmerson Veloso
Emerson Veloso
EFEnio Ferreira
Enio Ferreira
LBLucíola S. Barcelos
Lucíola S. Barcelos
MLMiriam Lopes
Miriam Lopes
Background: P1G10 is a cysteine proteolytic fraction from Vasconcellea cundinamarcensis latex, obtained by chromatographic separation on Sephadex-G10 and ultrafiltration. This fraction enhances healing in different models of skin lesions, and displays a protective/healing effect against gastric ulcers, where it was suggested an antioxidant role. Methods: We evaluated here the effect of topical treatment with P1G10, in mice lesions induced by UVB. Results: After single exposure to 2.4 J cm−2 UVB, P1G10 reduced erythema, increased cellularity of hypodermis, enhanced MPO activity and IL1β, and inhibited COX2 levels. These results point to an anti-inflammatory effect by P1G10. This fraction displayed antioxidant activity by reversing the depletion of glutathione (GSH), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and reducing the catalase activity increased by UVB. These changes may be related to a reduction in MDA observed in groups treated with P1G10. P1G10 also inhibited MMP-9, caspase-3 and pkat while increasing p53 levels.